Concepedia

Remko A. Bakker

RA

52

Publications

3.9K

Citations

34

H-Index

1997

Active since

Affiliations

Vrije Universiteit Amsterdam(Current)

Institute of Medicinal Plant Development

Boehringer Ingelheim (Germany)

UCB Pharma (Belgium)

Naresuan University

Remko A. Bakker is an author at Vrije Universiteit Amsterdam specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1997–2022

52

Publications

52

Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors

Rolf Grempler, Leo Thomas, Matthias Eckhardt et al. · Diabetes Obesity and Metabolism · 2011 · 583 citations

Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist

Herman D. Lim, Richard M. van Rijn, Ping Ling et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 276 citations · Full text

Histamine H<sub>1</sub>-Receptor Activation of Nuclear Factor-κB: Roles for Gβγ- and Gα<sub>q/11</sub>-Subunits in Constitutive and Agonist-Mediated Signaling

Remko A. Bakker, Stefan B. J. Schoonus, Martine J. Smit et al. · Molecular Pharmacology · 2001 · 254 citations

Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28

Paola Casarosa, Remko A. Bakker, Dennis Verzijl et al. · Journal of Biological Chemistry · 2001 · 242 citations · Full text

Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists

Remko A. Bakker, Kerstin Wieland, Henk Timmerman et al. · European Journal of Pharmacology · 2000 · 166 citations

, , +9

Rows per page

1–5 of 52